Skip to main content
. Author manuscript; available in PMC: 2017 Mar 16.
Published in final edited form as: Int J Pharm. 2016 Jan 16;500(0):255–267. doi: 10.1016/j.ijpharm.2016.01.031

Figure 3.

Figure 3

Relationship between route of administration, ADF design features, product performance characteristics and matrices for evaluation. *Evaluation of the performance of prodrug should consider the mechanism and rate of the conversion under various conditions.